Life Biosciences has appointed Mehmood Khan to serve as its CEO. Khan joins Boston-based Life Bio from PepsiCo (NASDAQ: [[ticker:PEP]]), where he was vice chairman and chief scientific officer. His experience also includes time at Takeda Pharmaceutical (NYSE: [[ticker:TAK]]), where he was president of the Takeda Global Research & Development Center. In January, Life Bio closed $50 million in Series B funding to continue its research of therapies treating diseases of aging.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
